AMSTERDAM–(BUSINESS WIRE)– #Avanzanite–Avanzanite Bioscience B.V., a European pharmaceutical company focused on rare diseases, today announced the expansion of its United Kingdom (UK) presence and the appointment of Sarah O’Connell as UK Country Manager. The move strengthens Avanzanite’s long-term commitment to the UK and its ability to help eligible patients access innovative rare disease medicines. “The UK is essential to our ambition of building Avanzanite into a European rare disease champion. We feel